STOCK TITAN

TILRAY BRANDS INC Stock Price, News & Analysis

TLRY Nasdaq

Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.

Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.

Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.

All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.

Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.

Rhea-AI Summary

Tilray Brands, Inc. (TLRY) will announce its financial results for the fourth quarter and fiscal year ending May 31, 2022, before the market opens on July 28, 2022. A live audio webcast will take place at 8:30 am ET, providing insights into the company's performance. Shareholders can submit questions to the executive team via the Say Technologies platform until July 27, 2022. Tilray is a prominent cannabis and consumer packaged goods company operating globally, offering innovative products and brands that cater to health and wellbeing needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.6%
Tags
-
Rhea-AI Summary

Tilray Brands announced the closure of its acquisition of a secured convertible note from HEXO Corp, valued at $155 million, representing a 10.8% discount on its $173.7 million balance. This strategic alliance aims to enhance operational efficiencies and drive product innovation, potentially yielding up to $80 million in cost savings over two years. The acquisition is expected to be immediately accretive to EPS and boost Tilray's market position, especially in anticipation of U.S. federal legalization opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Tilray Brands announced the launch of Hash-Infused Pre-Rolls under its Good Supply brand, available across Québec at the Société Québécoise du cannabis (SQDC). The new product combines strains Jean Guy and Starwalker Kush with a premium hash blend, offering an average THC level of around 26%. Good Supply has established itself as a top-selling cannabis brand in Canada, known for its innovative product range. This launch aims to meet growing consumer demand for higher potency pre-rolls.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.02%
Tags
none
Rhea-AI Summary

Tilray Brands (Nasdaq: TLRY) announced the expansion of its medical cannabis offerings in the UK through its division, Tilray Medical. This marks the broadest portfolio of cannabis flower available in the UK, featuring high THC products cultivated in its EU-GMP-certified facility in Portugal. The range includes THC potencies from 10% to 25%, ensuring consistent and high-quality medical cannabis for patients. The company aims to meet the increasing demand for medical cannabis in the UK, providing safe access to a variety of treatment options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.78%
Tags
none
-
Rhea-AI Summary

Tilray Brands, Inc. (Nasdaq: TLRY) recently hosted a delegation from the Luxembourg Ministry of Health at its EU-GMP-certified facility in Cantanhede, Portugal. This visit aimed to showcase Tilray's high-quality medical cannabis operations, which serve patients in Luxembourg and Europe. Managing Director Sascha Mielcarek emphasized the company's commitment to meeting the growing demand for cannabis legalization in Europe. Tilray has established itself as a leader in cannabis production and export, with a strong presence in 20 countries, providing a range of medical cannabis brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
none
-
Rhea-AI Summary

Tilray Brands announced the launch of a new summer lineup of premium craft-cannabis products under its Broken Coast brand, available across Canada. The lineup includes Butane Hash Oil (BHO) vapes and premium small-batch cannabis flower. Highlights include Amnesia Haze Live Resin 510 Vapes with 75% THC, Up In The Sky Liquid Wax Vapes with 73%-80% THC, and a variety of small-batch flowers, such as Sour OG and Sunset Sherbet. These products aim to enhance the consumer experience with full-spectrum extracts and unique terpene profiles.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
none
Rhea-AI Summary

Tilray Brands (TLRY) has amended its agreements to acquire the HEXO Note, announcing an increased discount on the purchase price and a reduced conversion price for HEXO shares. The revised terms include a 10.8% discount on the $185 million outstanding principal and adjust the conversion price from CAD$0.85 to CAD$0.40 per share. The strategic alliance is expected to yield up to $80 million in shared cost-saving synergies over two years. Closing of the transaction is anticipated by July 15, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
none
-
Rhea-AI Summary

Tilray Brands has launched its first CBN oil product, CBN Night Oil, under the Aphria medical cannabis brand, aimed at improving sleep quality for patients. The product contains 30mg CBN and 10mg THC per mL in a 50mL bottle, and is now available across Canada. Blair MacNeil, President of Tilray Canada, emphasized the company's commitment to providing high-quality cannabinoid-based medicine. Tilray operates in over 20 countries and aims to expand its medical cannabis portfolio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.77%
Tags
none
-
Rhea-AI Summary

Tilray Brands has launched POLLEN, a new CBD lifestyle brand, on Amazon UK, aimed at enhancing wellness routines. POLLEN features three product lines: Powerbank, for energy; No Pressure, for stress relief; and Soothe You, for balance. Each product contains flavorful, vegan-friendly ingredients and 300mg of CBD per pack, independently tested for accurate dosage. The brand promotes normalization of CBD use through education and community engagement. POLLEN's products are currently exclusive to Amazon UK, with plans for broader retail availability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.43%
Tags
none
Rhea-AI Summary

Tilray Brands (Nasdaq: TLRY) has launched Good Supply TV, a new educational video series, alongside an expansion of its Good Supply cannabis portfolio. The new offerings include high-potency products such as liquid wax vapes and unique flower strains like Sweet Berry Kush and Monkey Butter in Canada. These products aim to enhance consumer knowledge and enjoyment while catering to the growing market of concentrate enthusiasts. The series is intended to provide key insights for budtenders and consumers alike.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.36%
Tags
none

FAQ

What is the current stock price of TILRAY BRANDS (TLRY)?

The current stock price of TILRAY BRANDS (TLRY) is $0.6113 as of July 17, 2025.

What is the market cap of TILRAY BRANDS (TLRY)?

The market cap of TILRAY BRANDS (TLRY) is approximately 694.3M.
TILRAY BRANDS INC

Nasdaq:TLRY

TLRY Rankings

TLRY Stock Data

694.34M
1.00B
0.65%
11.72%
17.36%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
NEW YORK